Sun‐Wei Guo

ORCID: 0000-0002-8511-7624 · 225 papers in corpus
meta-analysis 2023
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2023.102433

High-intensity focused ultrasound (HIFU) has emerged as a promising uterus-sparing and possibly fertility-sparing treatment modality for women with adenomyosis, especially those who desire to conceive. We conducted this systematic review an…

guideline 2023
Reproductive medicine and biology ·doi:10.1002/rmb2.12535

This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.

guideline 2023
·doi:10.60692/bx9f2-cbt30

This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.

guideline 2023
·doi:10.60692/3zxsn-ep687

This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.

review 2023
Journal of clinical medicine ·doi:10.3390/jcm12030842

Widely viewed as an enigmatic disease, adenomyosis is a common gynecological disease with bewildering pathogenesis and pathophysiology. One defining hallmark of adenomyotic lesions is cyclic bleeding as in eutopic endometrium, yet bleeding …

review 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.03.021

Currently, hormonal drugs are the mainstay for treating endometriosis or adenomyosis. Aside from staying within the "therapeutic window" and cutting off the hormonal support to the ectopic endometrium, none of these treatments were develope…

lab-animal 2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00955-w

BACKGROUND: Women with endometriosis have been shown to have a reduced vagal tone as compared with controls and vagotomy promoted while vagus nerve stimulation (VNS) decelerated the progression of endometriosis in mice. Extensive research a…

review 2022
Reproductive medicine and biology ·doi:10.1002/rmb2.12438

PURPOSE: To analyze the characteristics of the ovarian endometrioma (OE) across the life span of a woman. In the past, the OE has traditionally been viewed as a single, monolithic disease. Today, there are emerging data indicating that OE p…

observational 2022
·doi:10.21203/rs.3.rs-1951340/v2

Abstract Neonatal uterine bleeding (NUB) has been postulated to cause early-onset endometriosis, but so far there has been no information on whether young women with a history of NUB may manifest various symptoms related to endometriosis. …

other 2022
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2022.07.009

RESEARCH QUESTION: Would a properly designed educational programme offered to young women improve their awareness and fundamental knowledge of menstrual pain and endometriosis? DESIGN: A multinational cross-sectional study using a pen-and-…

review 2022
Reproduction (Cambridge, England) ·doi:10.1530/REP-22-0224

IN BRIEF: Traditionally viewed as enigmatic and elusive, adenomyosis is a fairly common gynecological disease but is under-recognized and under-researched. This review summarizes the latest development on the pathogenesis and pathophysiolog…

review 2022
·doi:10.1530/rep-22-0224

In brief Traditionally viewed as enigmatic and elusive, adenomyosis is a fairly common gynecological disease but is under-recognized and under-researched. This review summarizes the latest development on the pathogenesis and pathophysiology…

lab-animal 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-01066-y

Heavy menstrual bleeding (HMB) is common and severely affects the quality of life of the afflicted women. While HMB is known to be caused by impaired endometrial repair after menstruation, its more proximate cause remains unknown. To invest…

guideline 2022
Human Reproduction ·doi:10.1093/humrep/deac166

STUDY QUESTION: What outcomes should be reported in all studies investigating uterus-sparing interventions for treating uterine adenomyosis? SUMMARY ANSWER: We identified 24 specific and 26 generic core outcomes in nine domains. WHAT IS K…

other 2022
Reproduction & fertility ·doi:10.1530/raf-22-0041

IN VITRO: culturing of endometrial cells obtained from the uterine mucosa or ectopic sites is used to study molecular and cellular signalling relevant to physiologic and pathologic reproductive conditions. However, the lack of consensus on …

observational 2022
Reproductive medicine and biology ·doi:10.1002/rmb2.12442

PURPOSE: To investigate how the extent of fibrosis in adenomyosis lesions contributes to heavy menstrual bleeding (HMB). METHODS: We recruited 57 women with histologically confirmed adenomyosis, 29 of whom reported moderate/heavy bleeding …

observational 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.04.016

OBJECTIVE: To investigate whether lesional immunostaining of putative biomarkers of recurrence and the extent of lesional and cortical fibroses are correlated with the severity of dysmenorrhea and serum antimüllerian hormone (AMH) levels in…

review 2022
Journal of clinical medicine ·doi:10.3390/jcm12010287

Adenomyosis is a complex and poorly understood gynecological disease. It used to be diagnosed exclusively by histology after hysterectomy; today its diagnosis is carried out increasingly by imaging techniques, including transvaginal ultraso…

lab-animal 2022
Biomedicines ·doi:10.3390/biomedicines10112893

In endometriosis, it has been widely believed that the local immunological milieu is Th2-skewed. Regulatory T cells (Tregs) promote fibrogenesis of endometriosis through the transforming growth factor β1 (TGF-β1) and platelet-derived growth…

2022
Reproductive and developmental medicine ·doi:10.1097/rd9.0000000000000012

Objective: Despite the fact that adenomyosis is a fairly common gynecological disorder, its pathogenesis remains elusive. Several theories on the pathogenesis of adenomyosis have been proposed, but none of them has been proven experimentall…

2022
·doi:10.1007/978-3-030-97236-3_4
lab-animal 2022
Biomedicines ·doi:10.3390/biomedicines10061218

We have recently demonstrated that endometrial-myometrial interface (EMI) disruption (EMID) can cause adenomyosis in mice, providing experimental evidence for the well-documented epidemiological finding that iatrogenic uterine procedures in…

lab-animal 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00813-x

The development of more efficacious, non-hormonal therapeutics for endometriosis is still an unmet medical need begging to be fulfilled. Growing evidence indicates that endometriotic lesions are wounds undergoing repeated tissue injury and …

2022
·doi:10.18103/mra.v10i11.3341

So far, the pressing need for the development of non-hormonal therapeutics for endometriosis has been unfulfilled. In light of the evidence that platelets play important roles in the development of endometriosis and that tetramethylpyrazine…

review 2022
Journal of clinical medicine ·doi:10.3390/jcm11061744

BACKGROUND: Adenomyosis is a common gynecological disorder traditionally viewed as "elusive". Several excellent review papers have been published fairly recently on its pathogenesis, and several theories have been proposed. However, the fal…